Agonist-Based Adjuvants for Enhanced Vaccine Efficacy
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is excited to announce the launch of its new line of Agonist-Based Adjuvants to support researchers in various fields, including vaccines and immunotherapeutics. These new adjuvants are designed to significantly accelerate vaccine research and development by enhancing immune responses and...
0 Commentaires 0 Parts 16 Vue 0 Aperçu
Commandité